Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and Tauopathies

cyc 202 has been researched along with Tauopathies in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, CX; Hu, F; Huang, HZ; Li, K; Liu, D; Liu, FF; Wang, JZ; Xie, AJ; Zhu, LQ1
Huttunen, HJ; Kysenius, K; Nykänen, NP; Sakha, P; Tammela, P1
Brun-Zinkernagel, AM; Koulen, P; Liu, R; Simpkins, JW; Wen, Y; Yang, S1
Green, KN; Kitazawa, M; LaFerla, FM; Oddo, S; Yamasaki, TR1
Brun-Zinkernagel, AM; Koulen, P; Liu, R; Perez, EJ; Simpkins, JW; Wen, Y; Yang, SH1

Other Studies

5 other study(ies) available for cyc 202 and Tauopathies

ArticleYear
Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5.
    Molecular neurobiology, 2016, Volume: 53, Issue:1

    Topics: Alzheimer Disease; Animals; Calpain; Cholinergic Neurons; Cyclin-Dependent Kinase 5; Dendrites; Disease Models, Animal; Enzyme Activation; Humans; Mice; Olfactory Bulb; Phosphorylation; Purines; Roscovitine; Septal Nuclei; Solubility; tau Proteins; Tauopathies

2016
γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
    The Journal of biological chemistry, 2012, Feb-24, Volume: 287, Issue:9

    Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Cytoskeleton; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Marine Toxins; Mice; Naphthoquinones; Nerve Degeneration; Neuroblastoma; NIMA-Interacting Peptidylprolyl Isomerase; Oxazoles; Peptidylprolyl Isomerase; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Purines; Rats; Receptors, GABA-A; Roscovitine; tau Proteins; Tauopathies

2012
Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats.
    The Journal of biological chemistry, 2004, May-21, Volume: 279, Issue:21

    Topics: Alzheimer Disease; Animals; Antigens; Apoptosis; Brain Ischemia; Cell Cycle; Cell Death; Cerebral Cortex; Enzyme Inhibitors; Epitopes; Estradiol; Female; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Ischemia; Microscopy, Electron; Microscopy, Fluorescence; Mitosis; Neurons; Phosphorylation; Protein Conformation; Protein Kinases; Purines; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Roscovitine; Tauopathies; Time Factors

2004
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Sep-28, Volume: 25, Issue:39

    Topics: Aging; Alzheimer Disease; Animals; Cyclin-Dependent Kinase 5; Disease Models, Animal; Encephalitis; Enzyme Activation; Female; Hippocampus; Lipopolysaccharides; Male; Mice; Mice, Transgenic; Microglia; Neural Pathways; Phosphorylation; Protein Kinase Inhibitors; Purines; Roscovitine; tau Proteins; Tauopathies

2005
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats.
    Biochimica et biophysica acta, 2007, Volume: 1772, Issue:4

    Topics: Animals; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Disease Models, Animal; Female; Functional Laterality; Ischemic Attack, Transient; Neurofibrillary Tangles; Phosphorylation; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Tauopathies

2007